Can “risk-sharing” agreements enable fast access to COVID-19 vaccines?
As the global COVID-19 pandemic has progressed, so too have efforts to develop, manufacture, and secure the supply of potentially effective vaccines. But...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Debate around the nature and content of environmental, social, and governance (ESG) strategies and disclosures continues to accelerate, with a resultant evolution in associated standards and regulations. CRA’s multidisciplinary professionals provide an integrated suite of services that are strategically and operationally relevant across the sustainability journey and are well positioned to serve the varied and changing needs of companies, boards, executive teams, investors, lenders, and their counsel.
As the global COVID-19 pandemic has progressed, so too have efforts to develop, manufacture, and secure the supply of potentially effective vaccines. But...
As biopharmaceutical companies work to develop vaccines for COVID-19, multiple frameworks are being developed to guide their ethical allocation. Consultants...